CHLA Clinical Research Studies
Having volunteers participate in research studies and clinical trials is critical to our research efforts. Thousands of children and families are involved in our patient-centered studies every year. Many of the treatments used today are based on the results of past research studies and clinical trials conducted with our patients. Our scientific and clinical experts take the best ideas from the laboratory -- to the patient -- in the form of promising new treatments.
By searching our study directory, you may identify research that could impact the life of your child or of another child you know. Because the number of available research studies and clinical trials for children nationwide is small, every participant makes a significant contribution.
In addition to enrolling children with certain diseases in order to study treatments and prevention of those diseases, we also need to study healthy children. Ask your child’s doctor about volunteer study options that may be suitable for your child.
Please contact the study staff listed in your search results for more information.
Back to the full listing
|Study Details - ID: CHLA-18-00134|
|Purpose of Research:|
To test the effectiveness of an addiction-based weight loss intervention, embodied first as a smartphone app with telephone coaching (AppCoach) compared to (1) addiction model based weight-loss app alone (App) and (2) multi-disciplinary in-clinic weight loss intervention (Clinic) on weight outcomes of overweight and obese adolescents at 3, 6, 12 and 18 months post enrollment.
An Addiction-Based Mobile Health Weight Loss Intervention With Coaching
|Full Title of Study:|
An Addiction Model Based Mobile Health Weight Loss Intervention With Coaching in Adolescents With Overweight and Obesity: Multi-Site Randomized Controlled Trial
|Phase/Type of Study:|
Phase 1 - Interventional
1. Age 14-18 years 2. Able to read English 3. Body mass index [BMI] ≥85th percentile for age and gender
18 months: group 1 and 2: 5 visits group 3: 9 visits Compensation provided.
Alaina Vidmar, MD
|Coordinator Contact Name:|
323-361-7971 or 323-361-6446
|Clinical Trials .Gov Identifier:NCT03500835|